2009
DOI: 10.1136/bmj.b277
|View full text |Cite
|
Sign up to set email alerts
|

Change in moles linked to use of unlicensed "sun tan jab"

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(30 citation statements)
references
References 4 publications
0
30
0
Order By: Relevance
“…Cardones and Grichnik 79 described a 40-year-old male who developed multiple new DN following self administration of α-melanocyte-stimulating hormone. Similarly, Langan et al 80 reported two patients presenting with new and rapidly changing DN following subcutaneous injection of melanotan I and II.…”
Section: Epidemiology and Natural Historymentioning
confidence: 85%
“…Cardones and Grichnik 79 described a 40-year-old male who developed multiple new DN following self administration of α-melanocyte-stimulating hormone. Similarly, Langan et al 80 reported two patients presenting with new and rapidly changing DN following subcutaneous injection of melanotan I and II.…”
Section: Epidemiology and Natural Historymentioning
confidence: 85%
“…To quote Lin and Fisher (2007), "could it be that keratinocytes are the primary UV responding population, and melanoma formation is largely a consequence of reactive secondary stimulation?" In fact the injection of highly active MSH analogues may be naevis promoting (Cardones et al, 2009;Langan et al, 2009). However the notion of UVR-induced melanocyte proliferation being melanomagenic is at odds with findings that stimulation of melanocytes with factor such as a-MSH (e.g.…”
Section: Uvr-induced Proliferation Of Melanocytesmentioning
confidence: 43%
“…Descriptions of acute and chronic effects of melanotan are consistent with clinical literature (Cardones et al, 2009;Cousen et al, 2009;Dorr et al, 1996;Ellis et al, 2009;FerrandizPulido et al, 2011;Langan et al, 2009;Paurobally et al, 2011;Rhodes & Langan, 2011;Thestrup-Pedersen & Sondergaardm, 2010;Thestrup-Pedersen, 2011;von Bartenwerffer, Siebenhaar, & Hunzelmann, 2011;Wessells et al, 1998Wessells et al, , 2000. Negative outcomes were managed proactively with monitoring of dosage, administration of pharmaceuticals and restricted photo therapy.…”
Section: Discussionmentioning
confidence: 62%
“…Dysplastic changes in existing nevi, eruptive atypical melanocytic nevi or appearance of new lesions and freckles following melanotan use are common (Burian, 2013;Cardones, Rand, & Richnik, 2009;Cousen et al, 2009;Ferrandiz-Pulido, Fernandez-Figueras, Quer, & Ferrandiz, 2011;Hueso-Gabriel et al, 2012;Javed et al, 2013;Langan, Ramlogan, Jamieson, & Rhodes, 2009;Langan et al, 2010;Ong & Bowling, 2012;Paurobally et al, 2011;Reid, Fitzgerald, Fabre, & Kirby, 2013;Sivyer, 2012;Thestrup-Pedersen & Sondergaard, 2010). Cases of malignant melanomas have also been reported (Ellis, Kirkham, & Seukeran, 2009;Paurobally et al, 2011Paurobally et al, , 2013.…”
Section: E-mail Address: Mcvanhout@witiementioning
confidence: 96%